155 related articles for article (PubMed ID: 17119996)
1. Survival after primary enucleation for choroidal melanoma: changes induced by the introduction of conservative therapies.
Gambrelle J; Grange JD; Devouassoux Shisheboran M; Rivoire M; Baggetto LG; Jean-Louis B; Fleury J; Kodjikian L
Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):657-63. PubMed ID: 17119996
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
3. No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter.
Sabazade S; Herrspiegel C; Gill V; Stålhammar G
BMC Cancer; 2021 Nov; 21(1):1270. PubMed ID: 34819035
[TBL] [Abstract][Full Text] [Related]
4. Impact of enucleation versus plaque radiotherapy in the management of juxtapapillary choroidal melanoma on patient survival.
De Potter P; Shields CL; Shields JA; Cater JR; Tardio DJ
Br J Ophthalmol; 1994 Feb; 78(2):109-14. PubMed ID: 8123617
[TBL] [Abstract][Full Text] [Related]
5. Survival following enucleation versus plaque radiotherapy in statistically matched subgroups of patients with choroidal melanomas: results in patients treated between 1980 and 1987.
Augsburger JJ; Schneider S; Freire J; Brady LW
Graefes Arch Clin Exp Ophthalmol; 1999 Jul; 237(7):558-67. PubMed ID: 10424306
[TBL] [Abstract][Full Text] [Related]
6. [Survival rates for large choroidal melanomas].
Stoiukhina AS; Chesalin IP
Vestn Oftalmol; 2014; 130(4):39-44. PubMed ID: 25306722
[TBL] [Abstract][Full Text] [Related]
7. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-dependent covariates.
Egan KM; Ryan LM; Gragoudas ES
Arch Ophthalmol; 1998 Mar; 116(3):366-70. PubMed ID: 9514491
[TBL] [Abstract][Full Text] [Related]
8. Cobalt-60 plaque radiotherapy vs enucleation for posterior uveal melanoma.
Augsburger JJ; Gamel JW; Lauritzen K; Brady LW
Am J Ophthalmol; 1990 May; 109(5):585-92. PubMed ID: 2333923
[TBL] [Abstract][Full Text] [Related]
9. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19.
Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
Ophthalmology; 2002 Dec; 109(12):2197-206. PubMed ID: 12466159
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
[TBL] [Abstract][Full Text] [Related]
11. Matched group study of preenucleation radiotherapy versus enucleation alone for primary malignant melanoma of the choroid and ciliary body.
Augsburger JJ; Lauritzen K; Gamel JW; Lowry JC; Brady LW
Am J Clin Oncol; 1990 Oct; 13(5):382-7. PubMed ID: 2220658
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical outcomes for patients with large choroidal melanoma after primary treatment with enucleation or proton beam radiotherapy.
Mosci C; Lanza FB; Barla A; Mosci S; Hérault J; Anselmi L; Truini M
Ophthalmologica; 2012; 227(4):190-6. PubMed ID: 22269846
[TBL] [Abstract][Full Text] [Related]
13. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G
Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for survival after enucleation for choroidal melanoma.
Baldi G; Baldi F; Maguire M; Massaro-Giordano M
Int J Oncol; 1998 Dec; 13(6):1185-9. PubMed ID: 9824629
[TBL] [Abstract][Full Text] [Related]
15. Relative survival rates after alternative therapies for uveal melanoma.
Seddon JM; Gragoudas ES; Egan KM; Glynn RJ; Howard S; Fante RG; Albert DM
Ophthalmology; 1990 Jun; 97(6):769-77. PubMed ID: 2374681
[TBL] [Abstract][Full Text] [Related]
16. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10.
Am J Ophthalmol; 1998 Jun; 125(6):779-96. PubMed ID: 9645716
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors following enucleation of 111 uveal melanomas.
Coleman K; Baak JP; Van Diest P; Mullaney J; Farrell M; Fenton M
Br J Ophthalmol; 1993 Nov; 77(11):688-92. PubMed ID: 8280680
[TBL] [Abstract][Full Text] [Related]
18. An Australian choroidal melanoma survey. Factors affecting survival following enucleation.
Greer CH; Buckley C; Buckley J; Ramsay R; La Nauze L
Aust J Ophthalmol; 1981 Nov; 9(4):255-61. PubMed ID: 7342921
[TBL] [Abstract][Full Text] [Related]
19. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.
Hawkins BS;
Am J Ophthalmol; 2004 Dec; 138(6):936-51. PubMed ID: 15629284
[TBL] [Abstract][Full Text] [Related]
20. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
